You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Merck
McKesson
AstraZeneca
Johnson and Johnson
Medtronic
Dow

Last Updated: February 22, 2020

DrugPatentWatch Database Preview

Drug Price Trends for IMATINIB MESYLATE


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

Drug Price Trends for IMATINIB MESYLATE

Average Pharmacy Cost for IMATINIB MESYLATE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
IMATINIB MESYLATE 100 MG TAB 00378-2245-77 2.06865 EACH 2020-02-19
IMATINIB MESYLATE 100 MG TAB 00054-0248-22 2.06865 EACH 2020-02-19
IMATINIB MESYLATE 400 MG TAB 72485-0203-30 5.80958 EACH 2020-02-19
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for IMATINIB MESYLATE

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
IMATINIB MESYLATE 400MG TAB UD Major Pharmaceuticals 00904-6621-04 3X10 2798.66 2019-04-18 - 2023-11-30 FSS
IMATINIB MESYLATE 100MG TAB UD Major Pharmaceuticals 00904-6901-04 30 667.56 22.25200 EACH 2019-10-21 - 2023-11-30 FSS
IMATINIB MESYLATE 400MG TAB AvKare, Inc. 60505-2901-03 30 417.43 13.91433 EACH 2020-01-15 - 2022-12-31 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Boehringer Ingelheim
Johnson and Johnson
McKesson
Baxter
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.